Retrospective Analysis on Glucolipid Metabolism of 64 Patients with Liver Cirrhosis after Treatment with Recombinant Growth Hormone

Article Contents

Article Navigation > Journal of Kunming Medical University > 2011 > 32(05):

Retrospective Analysis on Glucolipid Metabolism of 64 Patients with Liver Cirrhosis after Treatment with Recombinant Growth Hormone[J]. Journal of Kunming Medical University, 2011, 32(05).

Citation:

Retrospective Analysis on Glucolipid Metabolism of 64 Patients with Liver Cirrhosis after Treatment with Recombinant Growth Hormone[J]. Journal of Kunming Medical University, 2011, 32(05).

Retrospective Analysis on Glucolipid Metabolism of 64 Patients with Liver Cirrhosis after Treatment with Recombinant Growth Hormone[J]. Journal of Kunming Medical University, 2011, 32(05).

Citation:

Retrospective Analysis on Glucolipid Metabolism of 64 Patients with Liver Cirrhosis after Treatment with Recombinant Growth Hormone[J]. Journal of Kunming Medical University, 2011, 32(05).

PDF( 0 KB)

Retrospective Analysis on Glucolipid Metabolism of 64 Patients with Liver Cirrhosis after Treatment with Recombinant Growth Hormone

Abstract

Abstract

Objective To retrospectively analyze the glucolipid metabolism in patients with liver cirrhosis after treatment with recombinant growth hormone.Methods We analyzed the triglycerides(TG),serum total cholesterol(TCH),fasting blood sugar(FBS),serum insulin(FINS)and insulin resistance index(IRS)in 64 patients with liver cirrhosis after treatment with recombinant growth hormone from January 2007 to June 2009.Results There was no statistically significant difference in each test index of patients with liver cirrh...
- Liver cirrhosis,
- Recombinant growth hormone,
- Glucolipid metabolism

FullText(HTML)

References(0)

References

Relative Articles(5)

Relative Articles

[1]	Kang HUANG, Zhirong ZHAO, Haiwen LI, Ti WU, Ting JIA, Lu WANG, Nihong LU, Yongrui YANG. Efficacy and Safety of Sofosbuvir/Velpatasvir with or without Ribavirin in Cirrhotic Patients with Genotype 3 Chronic Hepatitis C Infection. Journal of Kunming Medical University, 2023, 44(11): 126-134. doi: 10.12259/j.issn.2095-610X.S20231119
[2]	Siqi LI, Wenlin TAI. Significance of CXCL10 as a Biomarker of Liver Cirrhosis. Journal of Kunming Medical University, 2022, 43(7): 55-61. doi: 10.12259/j.issn.2095-610X.S20220711
[3]	Min ZHOU, Zhihui MA, Jiayan LI, Jianhua FAN, Ling LIN, Tingying YU, Huifang ZHANG, Li LIU. Predictive Model of Risk Factors for the Recurrence of Liver Cirrhosis with Pleural Effusion. Journal of Kunming Medical University, 2022, 43(5): 149-154. doi: 10.12259/j.issn.2095-610X.S20220524
[4]	. The Treatment of Liver Cirrhosis Complicated with Portal Hypertension by Transjugalar Intrahepatic Portosystemic Shunt (a Follow-up Study of 126 Cases). Journal of Kunming Medical University,
[5]	. Differential Diagnosis of Thrombus in Portal Vein System from Cancer Embolus by CT. Journal of Kunming Medical University,